Connection

Patrick Woster to Antineoplastic Agents

This is a "connection" page, showing publications Patrick Woster has written about Antineoplastic Agents.
Connection Strength

2.191
  1. Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis. Eur J Med Chem. 2018 Mar 25; 148:210-220.
    View in: PubMed
    Score: 0.347
  2. (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators. J Med Chem. 2010 Jul 22; 53(14):5197-212.
    View in: PubMed
    Score: 0.206
  3. Recent advances in the development of polyamine analogues as antitumor agents. J Med Chem. 2009 Aug 13; 52(15):4551-73.
    View in: PubMed
    Score: 0.193
  4. Polyamine-based analogues as biochemical probes and potential therapeutics. Biochem Soc Trans. 2007 Apr; 35(Pt 2):356-63.
    View in: PubMed
    Score: 0.164
  5. Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors. J Med Chem. 2005 Oct 06; 48(20):6350-65.
    View in: PubMed
    Score: 0.148
  6. Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues. Proc West Pharmacol Soc. 2005; 48:24-30.
    View in: PubMed
    Score: 0.140
  7. The role of polyamine catabolism in anti-tumour drug response. Biochem Soc Trans. 2003 Apr; 31(2):361-5.
    View in: PubMed
    Score: 0.124
  8. Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. Molecules. 2022 Jun 08; 27(12).
    View in: PubMed
    Score: 0.117
  9. Terminally alkylated polyamine analogues as chemotherapeutic agents. J Med Chem. 2001 Jan 04; 44(1):1-26.
    View in: PubMed
    Score: 0.106
  10. 1-(N-alkylamino)-11-(N-ethylamino)-4,8-diazaundecanes: simple synthetic polyamine analogues that differentially alter tubulin polymerization. J Med Chem. 1999 Apr 22; 42(8):1415-21.
    View in: PubMed
    Score: 0.094
  11. Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies. PLoS One. 2018; 13(8):e0202677.
    View in: PubMed
    Score: 0.090
  12. Growth and biochemical effects of unsymmetrically substituted polyamine analogues in human lung tumor cells 1. Cancer Chemother Pharmacol. 1995; 36(1):69-74.
    View in: PubMed
    Score: 0.070
  13. Synthesis and evaluation of unsymmetrically substituted polyamine analogues as modulators of human spermidine/spermine-N1-acetyltransferase (SSAT) and as potential antitumor agents. J Med Chem. 1993 Oct 01; 36(20):2998-3004.
    View in: PubMed
    Score: 0.064
  14. Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm. BMC Cancer. 2010 Oct 14; 10:555.
    View in: PubMed
    Score: 0.052
  15. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines. Cancer Chemother Pharmacol. 2010 May; 65(6):1067-81.
    View in: PubMed
    Score: 0.048
  16. Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines. J Biol Chem. 2005 Dec 02; 280(48):39843-51.
    View in: PubMed
    Score: 0.037
  17. Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cells. J Cell Physiol. 2000 Feb; 182(2):209-13.
    View in: PubMed
    Score: 0.025
  18. Effects of the polyamine analogues N1-ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-ethylN-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells. Clin Cancer Res. 2000 Jan; 6(1):17-23.
    View in: PubMed
    Score: 0.025
  19. Unsymmetrically substituted polyamine analogue induces caspase-independent programmed cell death in Bcl-2-overexpressing cells. Cancer Res. 1998 Jul 01; 58(13):2711-4.
    View in: PubMed
    Score: 0.022
  20. The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci U S A. 1997 Oct 14; 94(21):11557-62.
    View in: PubMed
    Score: 0.021
  21. Targeting polyamine metabolism for cancer therapy and prevention. Biochem J. 2016 10 01; 473(19):2937-53.
    View in: PubMed
    Score: 0.020
  22. Polyamine analogue induction of programmed cell death in human lung tumor cells. Clin Cancer Res. 1996 Mar; 2(3):441-6.
    View in: PubMed
    Score: 0.019
  23. Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue. Cancer Res. 1995 Aug 01; 55(15):3233-6.
    View in: PubMed
    Score: 0.018
  24. Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert Rev Mol Med. 2013 Feb 22; 15:e3.
    View in: PubMed
    Score: 0.015
  25. Novel Pt(II) and Pd(II) complexes with polyamine analogues: synthesis and vibrational analysis. J Inorg Biochem. 2012 Mar; 108:1-7.
    View in: PubMed
    Score: 0.014
  26. Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr Relat Cancer. 1999 Mar; 6(1):69-73.
    View in: PubMed
    Score: 0.006
  27. Structural specificity of polyamines and polyamine analogues in the protection of DNA from strand breaks induced by reactive oxygen species. Biochem Biophys Res Commun. 1998 Mar 06; 244(1):298-303.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.